Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


ArthroCare completes Opus acquisition

This article was originally published in The Gray Sheet

Executive Summary

Coblation technology developer finalizes $130 mil. purchase of soft tissue orthopedic repair system maker Opus Medical Nov. 15 (1"The Gray Sheet" Sept. 13, 2004, p. 14). ArthroCare expects Opus to generate $16 mil.-$17 mil. in 2004 revenue from AutoCuff anchoring system sales...

You may also be interested in...

Bipolar RF Sales Injunction Vacated In Appeals Decision On ArthroCare Case

Smith & Nephew is evaluating whether to re-enter the bipolar radiofrequency (RF) market now that a sales injunction has been lifted by a Washington, D.C. federal appeals court

ArthroCare/Opus integration ahead of schedule

Coblation RF tissue removal tech developer will complete the transition of Opus Medical's manufacturing operations into its Costa Rica facility during the first half of 2005 following the Nov. 15 purchase of the soft tissue orthopedic repair system maker (1"The Gray Sheet" Nov. 22, 2004, In Brief). During the fourth quarter, ArthroCare brought Costa Rica's Opus production on line and completed planned distribution changes for Opus and Coblation product lines. ArthroCare's preliminary Q4 results include revenue of $42.7 mil., up 31.4%...

ArthroCare Rounds Out Rotator Cuff Offerings With $130 mil. Opus Acquisition

ArthroCare plans to introduce Opus Medical's AutoCuff anchoring system for bankart repair and slap procedures in early 2005

Related Content




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts